6 resultados
FIELD OF THE INVENTION
The present invention generally relates to formulations and methods for treating oral injury, oral inflammation, or oral pain by applying a wet formulation to the oral cavity.
BACKGROUND OF THE INVENTION
Human saliva plays a number of roles in the oral cavity, including aiding
TECHNICAL FIELD
The present invention relates to compositions and methods for treating a joint disease, including veterinary applications.
BACKGROUND
For example, articular cartilage is hyaline cartridge that is composed of a small number of cells, collagenous extracellular matrix, abundant
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-WEB and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Jan. 8, 2013, is named sequence.txt and is 3 KB.
TECHNICAL FIELD
The present invention relates to a
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a National Stage application of PCT/JP2008/052999, filed Feb. 21, 2008, which claims priority from Japanese applications JP 2007-041520, filed Feb. 21, 2007 and JP 2007-277005, filed Oct. 24, 2007.
TECHNICAL FIELD
The present invention
TECHNICAL FIELD
The present disclosure relates generally to thyroid hormone receptor antagonists (referred to as "thyrointegrin antagonists") and more specifically to alpha-V-beta-3 (.alpha.v.beta.3) integrin-thyroid hormone receptor antagonists conjugated via a non-cleavable bond of a linker with
TECHNICAL FIELD
The present disclosure relates generally to thyroid hormone receptor antagonists (referred to as "thyrointegrin antagonists") and more specifically to alpha-V-beta-3 (.alpha.v.beta.3) integrin-thyroid hormone receptor antagonists conjugated via a non-cleavable bond of a linker with